GLORIA OLSSON: Open Payments
NPI 1316516073 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 14 payments from 11 companies in 2025. Trend: 2023 $511 · 2024 $188 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $58 |
| Sequel Med Tech, LLC | 2 | $42 |
| Madrigal Pharmaceuticals | 1 | $22 |
| Tandem Diabetes Care, Inc. | 1 | $22 |
| Insulet Corporation | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| BETA BIONICS, INC. | 2 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: MINIMED 780G, TWIIST, REZDIFFRA, t:slim X2 Insulin Pump with Control-IQ, Omnipod, JARDIANCE, iLet Bionic Pancreas, LOKELMA.
Industry payments across WA — which companies pay providers there.
